MAPT and Brain atrophy: For example, tau deposition in the brain has recently been highlighted as a potential mediator of brain atrophy and cognitive decline related to vascular risk.46 Because the current study was not able to incorporate data regarding protein deposition (such as β-amyloid or tau), we are not able to entirely exclude the possibility of such a mediating factor.